These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 24870404

  • 1. A novel pathway for arsenic elimination: human multidrug resistance protein 4 (MRP4/ABCC4) mediates cellular export of dimethylarsinic acid (DMAV) and the diglutathione conjugate of monomethylarsonous acid (MMAIII).
    Banerjee M, Carew MW, Roggenbeck BA, Whitlock BD, Naranmandura H, Le XC, Leslie EM.
    Mol Pharmacol; 2014 Aug; 86(2):168-79. PubMed ID: 24870404
    [Abstract] [Full Text] [Related]

  • 2. Multidrug Resistance Protein 1 (MRP1/ABCC1)-Mediated Cellular Protection and Transport of Methylated Arsenic Metabolites Differs between Human Cell Lines.
    Banerjee M, Kaur G, Whitlock BD, Carew MW, Le XC, Leslie EM.
    Drug Metab Dispos; 2018 Aug; 46(8):1096-1105. PubMed ID: 29752257
    [Abstract] [Full Text] [Related]

  • 3. Polymorphic variants of MRP4/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions.
    Banerjee M, Marensi V, Conseil G, Le XC, Cole SP, Leslie EM.
    Biochem Pharmacol; 2016 Nov 15; 120():72-82. PubMed ID: 27659809
    [Abstract] [Full Text] [Related]

  • 4. Characterization of arsenic hepatobiliary transport using sandwich-cultured human hepatocytes.
    Roggenbeck BA, Carew MW, Charrois GJ, Douglas DN, Kneteman NM, Lu X, Le XC, Leslie EM.
    Toxicol Sci; 2015 Jun 15; 145(2):307-20. PubMed ID: 25752797
    [Abstract] [Full Text] [Related]

  • 5. Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1).
    Carew MW, Naranmandura H, Shukalek CB, Le XC, Leslie EM.
    Drug Metab Dispos; 2011 Dec 15; 39(12):2298-304. PubMed ID: 21918036
    [Abstract] [Full Text] [Related]

  • 6. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.
    Aposhian HV, Zakharyan RA, Avram MD, Sampayo-Reyes A, Wollenberg ML.
    Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):327-35. PubMed ID: 15276412
    [Abstract] [Full Text] [Related]

  • 7. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
    Hirano S, Kobayashi Y, Cui X, Kanno S, Hayakawa T, Shraim A.
    Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):458-67. PubMed ID: 15276427
    [Abstract] [Full Text] [Related]

  • 8. Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs).
    Leslie EM.
    J Inorg Biochem; 2012 Mar 01; 108():141-9. PubMed ID: 22197475
    [Abstract] [Full Text] [Related]

  • 9. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells.
    Wang TC, Jan KY, Wang AS, Gurr JR.
    Mutat Res; 2007 Feb 03; 615(1-2):75-86. PubMed ID: 17134727
    [Abstract] [Full Text] [Related]

  • 10. Differential Selectivity of Human and Mouse ABCC4/Abcc4 for Arsenic Metabolites.
    Whitlock BD, Ma Y, Conseil G, O'Brien AR, Banerjee M, Swanlund DP, Lin ZP, Wang Y, Le XC, Schuetz JD, Cole SPC, Leslie EM.
    Drug Metab Dispos; 2024 Nov 15; 52(12):1417-1428. PubMed ID: 39313329
    [Abstract] [Full Text] [Related]

  • 11. Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for the mutual detoxification of arsenic and selenium.
    Carew MW, Leslie EM.
    Carcinogenesis; 2010 Aug 15; 31(8):1450-5. PubMed ID: 20584751
    [Abstract] [Full Text] [Related]

  • 12. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E, Hartmann LM, Florea AM, von Recklinghausen U, Pieper R, Shokouhi B, Rettenmeier AW, Hirner AV, Obe G.
    Toxicol Appl Pharmacol; 2004 Dec 01; 201(2):156-65. PubMed ID: 15541755
    [Abstract] [Full Text] [Related]

  • 13. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
    Suzuki KT, Katagiri A, Sakuma Y, Ogra Y, Ohmichi M.
    Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):336-44. PubMed ID: 15276413
    [Abstract] [Full Text] [Related]

  • 14. Interaction of trivalent arsenicals with metallothionein.
    Jiang G, Gong Z, Li XF, Cullen WR, Le XC.
    Chem Res Toxicol; 2003 Jul 01; 16(7):873-80. PubMed ID: 12870890
    [Abstract] [Full Text] [Related]

  • 15. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India.
    Mandal BK, Ogra Y, Suzuki KT.
    Chem Res Toxicol; 2001 Apr 01; 14(4):371-8. PubMed ID: 11304125
    [Abstract] [Full Text] [Related]

  • 16. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang Z, Zhou J, Lu X, Gong Z, Le XC.
    Chem Res Toxicol; 2004 Jan 01; 17(1):95-103. PubMed ID: 14727923
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro study of intestinal transport of arsenite, monomethylarsonous acid, and dimethylarsinous acid by Caco-2 cell line.
    Calatayud M, Devesa V, Montoro R, Vélez D.
    Toxicol Lett; 2011 Jul 28; 204(2-3):127-33. PubMed ID: 21554932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.